ICON Other Current Assets 2010-2025 | ICLR
ICON other current assets from 2010 to 2025. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- ICON other current assets for the quarter ending March 31, 2025 were $1.197B, a 20.53% increase year-over-year.
- ICON other current assets for 2024 were $1.286B, a 35.12% increase from 2023.
- ICON other current assets for 2023 were $0.952B, a 0.6% decline from 2022.
- ICON other current assets for 2022 were $0.958B, a 53.69% increase from 2021.
| ICON Annual Other Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $1,286 |
| 2023 | $952 |
| 2022 | $958 |
| 2021 | $623 |
| 2020 | $429 |
| 2019 | $423 |
| 2018 | $363 |
| 2017 | $269 |
| 2016 | $193 |
| 2015 | $174 |
| 2014 | $146 |
| 2013 | $113 |
| 2012 | $62 |
| 2011 | $58 |
| 2010 | $58 |
| 2009 | $44 |
| ICON Quarterly Other Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,197 |
| 2024-12-31 | $1,286 |
| 2024-09-30 | $1,361 |
| 2024-06-30 | $1,231 |
| 2024-03-31 | $993 |
| 2023-12-31 | $952 |
| 2023-09-30 | $942 |
| 2023-06-30 | $985 |
| 2023-03-31 | $974 |
| 2022-12-31 | $958 |
| 2022-09-30 | $894 |
| 2022-06-30 | $709 |
| 2022-03-31 | $675 |
| 2021-12-31 | $623 |
| 2021-09-30 | $551 |
| 2021-06-30 | $415 |
| 2021-03-31 | $416 |
| 2020-12-31 | $429 |
| 2020-09-30 | $440 |
| 2020-06-30 | $410 |
| 2020-03-31 | $446 |
| 2019-12-31 | $423 |
| 2019-09-30 | $493 |
| 2019-06-30 | $492 |
| 2019-03-31 | $441 |
| 2018-12-31 | $363 |
| 2018-09-30 | $339 |
| 2018-06-30 | $275 |
| 2018-03-31 | $293 |
| 2017-12-31 | $269 |
| 2017-09-30 | $255 |
| 2017-06-30 | $249 |
| 2017-03-31 | $226 |
| 2016-12-31 | $193 |
| 2016-09-30 | $197 |
| 2016-06-30 | $190 |
| 2016-03-31 | $239 |
| 2015-12-31 | $174 |
| 2015-09-30 | $196 |
| 2015-06-30 | $68 |
| 2015-03-31 | $66 |
| 2014-12-31 | $146 |
| 2014-09-30 | $59 |
| 2014-06-30 | $100 |
| 2014-03-31 | $75 |
| 2013-12-31 | $62 |
| 2013-09-30 | $65 |
| 2013-06-30 | $49 |
| 2013-03-31 | $60 |
| 2012-12-31 | $62 |
| 2012-09-30 | $68 |
| 2012-06-30 | $173 |
| 2012-03-31 | $59 |
| 2011-12-31 | $58 |
| 2011-09-30 | $72 |
| 2011-06-30 | $66 |
| 2011-03-31 | $53 |
| 2010-12-31 | $58 |
| 2010-09-30 | $54 |
| 2010-06-30 | $51 |
| 2010-03-31 | $48 |
| 2009-12-31 | $44 |
| 2009-09-30 | $45 |
| 2009-06-30 | $41 |
| 2009-03-31 | $39 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.674B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.275B | 26.68 |
| CVS Health (CVS) | United States | $86.641B | 10.77 |
| Elevance Health (ELV) | United States | $86.192B | 11.12 |
| Cencora (COR) | United States | $58.035B | 20.19 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.934B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.811B | 17.69 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.798B | 0.00 |
| Solventum (SOLV) | United States | $13.056B | 13.82 |
| CochLear (CHEOY) | Australia | $12.649B | 0.00 |
| Revvity (RVTY) | United States | $11.530B | 19.84 |
| Viatris (VTRS) | United States | $10.575B | 3.63 |
| Avantor (AVTR) | United States | $9.220B | 13.40 |
| HealthEquity (HQY) | United States | $9.070B | 39.73 |
| Medpace Holdings (MEDP) | United States | $8.930B | 23.72 |
| Sonic Healthcare (SKHHY) | Australia | $8.455B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.368B | 14.44 |
| Caris Life Sciences,�Inc (CAI) | $6.821B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.386B | 25.83 |
| BrightSpring Health Services (BTSG) | United States | $4.138B | 37.97 |
| Sotera Health (SHC) | United States | $3.213B | 18.26 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.740B | 0.00 |
| Concentras Parent (CON) | United States | $2.711B | 15.67 |
| GeneDx Holdings (WGS) | United States | $2.599B | 100.11 |
| Organon (OGN) | United States | $2.563B | 2.72 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Ardent Health (ARDT) | United States | $1.957B | 8.34 |
| Progyny (PGNY) | United States | $1.878B | 41.34 |
| Premier (PINC) | United States | $1.779B | 13.51 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.475B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.205B | 9.17 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| CareDx (CDNA) | United States | $1.071B | 16.72 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.799B | 7.48 |
| Nutex Health (NUTX) | United States | $0.683B | 10.34 |
| LifeMD (LFMD) | United States | $0.625B | 0.00 |
| Embecta (EMBC) | United States | $0.563B | 3.80 |
| InnovAge Holding (INNV) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.484B | 39.83 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.259B | 0.00 |
| Beauty Health (SKIN) | United States | $0.246B | 0.00 |
| So-Young (SY) | China | $0.240B | 0.00 |
| Oncology Institute (TOI) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| Sera Prognostics (SERA) | United States | $0.154B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.120B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |